Dr Tran is currently appointed to the level of Adjunct Clinical Professor. He is Head of Haemostasis Thrombosis Unit and Director of the Haemophilia Treatment Centre (a state-wide service) at Alfred Health. The Alfred is a dynamic academic research organisation that is involved with basic science research and works to translate and integrate best evidence into routine standard of care, often in collaboration with The Australian Centre for Blood Diseases (ACBD) Monash University. Alfred Health is one of the premier organisations that thrives on delivering best care to complex patients.
Dr Tran is an active member of several research organisations, including the Haematology Clinical Research Unit (CRU), ACBD, Monash University, Thrombosis and Haemostasis Society of Australia and New Zealand (THANZ), and Australian Haemophilia Centres Directors’ Organisation (AHCDO). He has particular interests in the management of congenital haemophilia, venous thromboembolism (VTE) and its complications, rare bleeding disorders, immune platelet disorders and novel therapeutics. He has been the principal investigator for over 80 clinical trials in VTE diagnosis and management, haemophilia, and immune thrombocytopenia. He continues to supervise PhD (5), Master Phil (1), and numerous advanced haematology trainees.

He has a strong interest in standardising best practice and has led several published guidelines supported by specialty organisations in Australia, New Zealand and Asia Pacific regions. He is a strong supporter of medical education, training advanced haematology trainees (>30) and was a committee member of the Written Examination committee, Royal Australian College of Physicians (2008-15). He believes in the need to improve care in establishing countries and has lectured widely in the Asia-Pacific region, as well as, working with world federations societies for specific diseases. He is extremely active in AHCDO and THANZ, where he is the current Chair and Chair of the Clinical Trials Group (CTG) respectively. He works with governmental departments advisory boards and disease-specific advocacy groups to advocate for novel therapies to improve patient outcomes. He has a proven track record for leadership not only within Alfred Health but the wider community of haematology.

Related Links:

• Australian Centre for Blood Diseases
• Director, Clinical Thrombosis Centre, ACBD
• Director, Ronald Sawers Haemophilia Centre

Clinical focus & Service Provision

Diagnostic testing and treatment for patients with hereditary bleeding disorders began in 1954, and was incorporated into duties and service delivery from the laboratory haematology department. Services were redeveloped following the retirement of Dr Sawers and recognition of HIV infection in plasma recipients in 1984. It was subsequently recognised by the Department of Health as adult state centre for management of patients with hereditary bleeding disorders offering a multidisciplinary model of care that encompasses the diagnosis, treatment and long-term follow up. Currently, we are the only international haemophilia training centre in Australia.

The RSHC won the Twinning Centre of the year in 2013 by the World Federation of Haemophilia for educational work with the National Institute of Haematology and Blood Transfusion, Hanoi, Vietnam. Today approximately 1100 patients are registered with the centre and the number continues to rise. Prof Tran has led over 40 clinical trials since 2007.

Our comprehensive service includes Haemophilia and other hereditary bleeding disorders allowing the effective delivery of both inpatient and outpatient care.

We provide a consultative service to other specialties within The Alfred hospital. Patients are also referred to us for treatment from numerous centres within Melbourne and regional Victoria